https://www.selleckchem.com/products/azd2014.html
BACKGROUND Thrombocytopenia in cancer patients with an indication for anticoagulation poses a unique clinical challenge. There are guidelines for the setting of venous thromboembolism but not atrial fibrillation (AF). Evidence is lacking and current practice is unclear. OBJECTIVE To identify patient and physician characteristics associated with anticoagulation management in hematological malignancy and thrombocytopenia. METHODS A clinical vignette-based experiment was designed. Eleven hematologists were interviewed, identifying 5 releva
Like
Comment
Share
